Prime Medicine (PRME) Net Margin (2024 - 2026)
Prime Medicine's (PRME) quarterly Net Margin came in at 5738.55% in Q1 2026, down 216978.0% YoY from N/an in Q1 2025, and down 4.36% on a QoQ basis from 5498.69% in Q4 2025.
Prime Medicine (PRME) Net Margin (2024 - 2026) Analysis & Trends
Prime Medicine (PRME) has 3 years of Net Margin data on file, last reported at 5738.55% in Q1 2026.
- Quarterly Net Margin fell 216978.0% year-over-year to 5738.55% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4917.55% (up 33495.0% YoY) and the FY2025 annual result came in at 4342.44%, up 222417.0% from the prior year.
- Net Margin declined to 5738.55% in Q1 2026, from 5498.69% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 1936.6% in Q4 2024 to a low of 25128.23% in Q3 2024.
- A 3-year average of 7307.46% and a median of 5107.68% in 2025 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 2099909 bps in 2025, down 356209 bps in 2025.
- Tracing PRME's Net Margin over 3 years: stood at 1936.6% in 2024, then sank by 184 bps to 5498.69% in 2025, then dropped by 4 bps to 5738.55% in 2026.
- The last three Net Margin figures came in at 5738.55% (Q1 2026), 5498.69% (Q4 2025), and 4129.14% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Prime Medicine | 558.48 Mn | 558.48 Mn | - | -3,648.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,648.96% |
| Mar 31, 2026 | -5,738.55% |
| Dec 31, 2025 | -5,498.69% |
| Sep 30, 2025 | -4,129.14% |
| Jun 30, 2025 | -4,716.68% |
| Mar 31, 2025 | -3,568.78% |
| Dec 31, 2024 | -1,936.60% |
| Sep 30, 2024 | -25,128.23% |
| Mar 31, 2024 | -7,742.98% |